Big Win for Marijuana Reform Advocates but More Has to Be Done
Senate Hearing on Medical Marijuana Scheduled for Wednesday
By Steve Elliott
In a long-sought move anticipated by many marijuana reform advocates, the White House on Monday announced that it was removing a major obstacle to marijuana research – the Public Health Service (PHS) Review.
Rep. Earl Blumenauer (D-Oregon) welcomed the decision of the U.S. Department of Health and Human Services (HHS) to eliminate its Public Health Service (PHS) Review Committee for non-federally funded medical marijuana research – an additional review process not applied to other Schedule I substances. Last year, Rep. Blumenauer led a letter, signed by 29 other members of Congress, to the Secretary of HHS Sylvia Mathews Burwell requesting that this PHS process be eliminated.
“Today’s decision by HHS is a significant step toward improving an antiquated system that unfairly targets marijuana above and beyond other substances in research," Congressman Bluemanuer said. "I applaud the Administration in heeding our request and the request of many to eliminate this barrier.
"I hope this action will facilitate easier access to marijuana for medical researchers,” Rep. Blumenauer said. “Considering the widespread use of medical marijuana, it is absolutely essential that we allow doctors and scientists to research the therapeutic benefits and risks of its use.